LabCompass

Shangbin Yang

Immunology and Microbiology · The Ohio State University

Mid career · publishing since 2006Rising activity

Publications

60

Citations

1,338

Est. group size

Recurring co-author estimate

Active years

20

Publishing since 2006

Research summary
AI-generated

The bibliographic record under this name appears to combine work from multiple distinct research areas, including blood-clotting disorders and autoimmune disease (e.g., thrombotic thrombocytopenic purpura), cancer biology (drug resistance in gastric cancer), regenerative medicine, and unrelated engineering topics like AI-based crop disease detection and robotics pose estimation. Because these topics are highly disparate, this profile likely reflects a name-matching issue across several different researchers rather than one coherent research program. Prospective students should verify affiliation and topic focus directly with the individual before drawing conclusions from this data.

Blood clotting and coagulation disordersAutoimmune and hematologic diseaseCancer drug resistance mechanismsAgricultural AI and computer visionControl systems and robotics

Publication output has been irregular over the last decade, with a gap in 2021 followed by a notable spike in 2025, suggesting either variable activity or the merging of multiple distinct authors' records.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.2/year recently
2017: 4 publications172018: 2 publications182019: 2 publications192020: 2 publications20212022: 1 publication222023: 3 publications232024: 1 publication242025: 6 publications62526
Publishes in
  • Blood×7
  • Blood Advances×2
  • Agriculture×2
  • Frontiers in Oncology×1
  • Mathematics×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile